Technical Analysis: GILEAD SCIENCES, INC. (#GILD)

Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.


- #GILD exit the bearish channel at the end of December 2021

- Series of higher highs and higher lows since January 2021

- Lower end of the channel coincides with the 50MA

- MACD sloping up

- RSI at good level


Buy price at USD 64.55

1st TP at USD 68.00

2nd TP at USD 72.00

SL at 61.00



OTB Global Investments

London, 8 March 2021


4 views0 comments

Recent Posts

See All